4(i). immunization

Upload: nfacma

Post on 01-Jun-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/9/2019 4(i). Immunization

    1/51

    ImmunizationMartira MaddeppungengChild Health Department

    Medical Faculty Hasanuddin University

    Dr Wahidin Sudirohusodo Hospital

  • 8/9/2019 4(i). Immunization

    2/51

    The hepatitis Bvirus

    Bordetella pertussis

    The measles virus

    Clostridium tetani Corynebacterium

    diphtheriae

    Introduction

  • 8/9/2019 4(i). Immunization

    3/51

    ImmunizationGive protection on specific infection disease!accine"preventa#le disease$

    %he rights of the child&arents' health employer(s guaranteed thatimmunizations are availa#le for all children

  • 8/9/2019 4(i). Immunization

    4/51

  • 8/9/2019 4(i). Immunization

    5/51

    ImmunizationPassive

    Active

  • 8/9/2019 4(i). Immunization

    6/51

    &assive ImmunizationPassive immunity : get readymade antibodiesMaternal antibodies are transferred to the fetus

    through the placenta (3rd trimester !"ample: tetanus to"oid administered topregnant mother #ill decrease neonatal tetanus

  • 8/9/2019 4(i). Immunization

    7/51

    &assive Immunization$uman immunoglobulin to protect from measles%pecific immunoglobulin to protect from

    tetanus& diphtheria& hepatitis B& rabies' ( M)& varicella

  • 8/9/2019 4(i). Immunization

    8/51

    )ctive ImmunizationAdministration of antigenic material to stimulateimmune response li*e natural infection

    +ong life immunological memory+ong life protection to infection disease

  • 8/9/2019 4(i). Immunization

    9/51

    )ctive Immunization,sed:

    -hole organism (live or *illedomponent organism (sub unit vaccine&

    polisaccharide vaccineModification of organism product

    (to"oid vaccine

    Manufactur of organism component(recombinant vaccine

  • 8/9/2019 4(i). Immunization

    10/51

    Ideal !accine.ive protection on infection disease.ive long/life immunity

    0o side effect%ingle dosean be given by combination

  • 8/9/2019 4(i). Immunization

    11/51

    Ideal !accine *$!asy administration& no pain%table in many conditions

    an be *ept for long time duration1easonably priced

  • 8/9/2019 4(i). Immunization

    12/51

    Bacteria

    Virus Live : BCG

    Inactive: diphteria,pertussis, tetanus,cholera,pneumococcu

    s, meningococcus,Hib, Typhoid

    Live : OV , measles, varicella, parotitis,rubella, yello! "ever

    Inactive : in#uen$a,IV , rabies, Hepatitis%, Hepatitis B

  • 8/9/2019 4(i). Immunization

    13/51

    &&IProgram Pengembangan Imunisasi :

    B .

    $epatitis B2TPPolioMeasles

  • 8/9/2019 4(i). Immunization

    14/51

    Recommended Immunization Schedule

    (IDAI 2006)

    & )dminister * doses separated #y + ,ee-s or longer$ to children ≤ . years ,ho are receiving influenzavaccine for the first time or ,ho ,ere vaccinated for the first time last season #ut only received one dose

  • 8/9/2019 4(i). Immunization

    15/51

    'ecommended Immuni$ation (chedule

    )*+*

  • 8/9/2019 4(i). Immunization

    16/51

    BCG

    / Optimal administered age ) - months/ I" age . - months : /antou0 1 tuber2ulin test/ I" tuber2ulin pra BCG can not be done, BCG can beadministered,

    must be observed 3 days/ I" accelerated local reaction (+) , need "urtherevaluation

    4TB diagnostic5

  • 8/9/2019 4(i). Immunization

    17/51

    Hepatitis B

    %dministered 6rst HepB !ithin +) hours o"birth

  • 8/9/2019 4(i). Immunization

    18/51

    7T 8 olio

    9 O V administered !hen 6rst visit/ Baby that !as born in hospital : administered O V!hen baby

    !ill discharge "rom hospital to prevent viraltransmission to

    others baby/ Continue administer !ith OPV or IPV/ 7T vaccine "or children . ; !ee2s/ Can be administered 7T! or 7Ta or combination!ith Hep B

    or Hib/ 'epeat dose 7T should be administered at age +<

  • 8/9/2019 4(i). Immunization

    19/51

    /easles

    %dminister the second dose o" //' at

    age = 3 yearsBI%( rogram : proposed and updated!ith recommended immuni$ationschedule by health department

  • 8/9/2019 4(i). Immunization

    20/51

    0CG

  • 8/9/2019 4(i). Immunization

    21/51

    0CGBaby 3 months2ose : 4&45 ml I 6 I2

    1ight deltoidIf age 7 3 months : Mantou" 6 tuber*ulin test+evel of protection only 89 (-$; 54/

  • 8/9/2019 4(i). Immunization

    22/51

  • 8/9/2019 4(i). Immunization

    23/51

    2I&I 3 !)452e6adian I-utan &asca Imunisasi Vaccine AdverseEvents Report)0CG Superficial ulcus 7 ,ee-s crusta scar +"8 ,ee-s

    9imphadenitis : 0CG itisDisseminated 0CG"itis ; severe immunodeficiency

  • 8/9/2019 4(i). Immunization

    24/51

    D%&

  • 8/9/2019 4(i). Immunization

    25/51

    D%&Prevent diphteria& tetanus& pertussisontain: 2ipteria to"oid&

    Tetanus to"oid&Pertussis vaccine : / whole cell / acellular

  • 8/9/2019 4(i). Immunization

    26/51

  • 8/9/2019 4(i). Immunization

    27/51

  • 8/9/2019 4(i). Immunization

    28/51

  • 8/9/2019 4(i). Immunization

    29/51

    D%&Basic ; 3 times since age 9 months interval +"8 ,ee-s1epeat :

    " ?=/98 months 5/< years

    ?9 years (BIA% program: 2T $

  • 8/9/2019 4(i). Immunization

    30/51

    Contraindication D%&

    Absolute:is reaction

    *=!ncephalopathy )cutely severe neurologicaldisease ,ith long convulsion and?or decrease ofconsciousness and?or focal neurological disorder$

  • 8/9/2019 4(i). Immunization

    31/51

    • Specific precaution :ia

    *=Hypotonic hyporesponsiveness in+8 hours

    7= &ersistent crying @ 7 hours

    += History of convulsion 7 days afterimmunization

    Contraindication D%&

  • 8/9/2019 4(i). Immunization

    32/51

    'ecommended D%&D%& < ; *"+ monthsD%& * ; 7"A months

    D%& 7 ; +"B monthsD%& + ; < " * yearsD%& A ; A yearsD% B ;

  • 8/9/2019 4(i). Immunization

    33/51

    Table 2. Approximate rates of adverse event occurring within 48 hours DTP vaccination

    Event re!uenc"

    #ocal

    redness, swelling, pain 1 in 2-3 doses

    $ild%moderate s"stemic

    fever, drowsiness, fretfulness 1 in 2-3 doses

    vomiting, anorexia 1 in 5-15 doses

    $ore serious s"stemic

    persistent crying, fever 1 in 100-300 doses

    collapse, convulsions 1 in 1750 doses

    acute encephalopathy 1 in 100,000 doses

    permanent neurological deficit 1 in 300,000 doses

  • 8/9/2019 4(i). Immunization

    34/51

    &olio

  • 8/9/2019 4(i). Immunization

    35/51

    &olioPrevent : poliomyelitis Flaccid paralysis, pain at bac* and e"tremity

    Polio vaccine :+ive (%abin : oral @illed (%al* : parenteral

  • 8/9/2019 4(i). Immunization

    36/51

  • 8/9/2019 4(i). Immunization

    37/51

    Contraindication&olio : &!

    %emperature @ 78'AE CCorticosteroid' radiation

    MalignancyHI! infection or familySi#lings ,ith immunocompromised child

  • 8/9/2019 4(i). Immunization

    38/51

    'ecommended i &olio&olio < ; #ornD&% < &olio * ; *"+ months

    D&% * &olio 7 ; 7"A monthsD&% 7 &olio + ; +"B monthsD&% + &olio A ; < " * yearsD&% A &olio B ; A years

    D% B ;

  • 8/9/2019 4(i). Immunization

    39/51

    Hepatitis 0

  • 8/9/2019 4(i). Immunization

    40/51

    Hepatitis 0Prevent hepatitis B

    $epatitis B vaccine:2erivat plasma vaccine1ecombinant vaccine

  • 8/9/2019 4(i). Immunization

    41/51

  • 8/9/2019 4(i). Immunization

    42/51

    Hepatitis 0$B/? administered recom#inant vaccine H0 < mcgintramuscular' ,ithin

  • 8/9/2019 4(i). Immunization

    43/51

    Contraindication Hepatitis 01o contraindication' e>cept pregnant mother

  • 8/9/2019 4(i). Immunization

    44/51

    Measles

  • 8/9/2019 4(i). Immunization

    45/51

    MeaslesLive attenuated virusAge months

    2ose 4'5 ml %ontraindication : $igh fever& immunosupression&immunoglobulin or given blood component1epeat : age 5/< years

  • 8/9/2019 4(i). Immunization

    46/51

  • 8/9/2019 4(i). Immunization

    47/51

    Measles " !)45ever 5/?5 on A"B th day after immunization' for *days1ash 5 & on "< th day' for *"+ days4ncephalitis and encephalopathy 3 < ; < miiliondosis ,ithin 7 days after immunization

  • 8/9/2019 4(i). Immunization

    48/51

    1on &&I !accine$ibMM1Typhoid$epatitis A)aricellaInfluenza

    Pneumococcus

  • 8/9/2019 4(i). Immunization

    49/51

  • 8/9/2019 4(i). Immunization

    50/51

  • 8/9/2019 4(i). Immunization

    51/51